Thermo Fisher Scientific Long Term Debt 2010-2024 | TMO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Thermo Fisher Scientific long term debt for 2023 was $31.308B, a 8.3% increase from 2022.
Thermo Fisher Scientific long term debt for 2022 was $28.909B, a 10.59% decline from 2021.
Thermo Fisher Scientific long term debt for 2021 was $32.333B, a 69.22% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Thermo Fisher Scientific long term debt for 2023 was $31.308B, a 8.3% increase from 2022.
Thermo Fisher Scientific long term debt for 2022 was $28.909B, a 10.59% decline from 2021.
Thermo Fisher Scientific long term debt for 2021 was $32.333B, a 69.22% increase from 2020.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$174.1B
Alcon (ALC)	$48.5B
IQVIA Holdings (IQV)	$44.6B
IDEXX Laboratories (IDXX)	$42.6B
Edwards Lifesciences (EW)	$40.5B
DexCom (DXCM)	$28.8B
STERIS (STE)	$23.6B
SONOVA HOLDING (SONVY)	$21B
Waters (WAT)	$20.1B
Hologic (HOLX)	$19.1B
Sysmex ADR (SSMXY)	$12.5B
Fresenius Medical Care AG KGaA (FMS)	$12.2B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.6B
Penumbra (PEN)	$7.8B
Glaukos (GKOS)	$7.1B
Masimo (MASI)	$5.9B
TransMedics (TMDX)	$5.5B
Integer Holdings (ITGR)	$4.4B
PROCEPT BioRobotics (PRCT)	$4.3B
Tandem Diabetes Care (TNDM)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.7B
Inari Medical (NARI)	$2.6B
Elekta AB (EKTAY)	$2.5B
Nihon Kohden (NHNKY)	$2.3B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.1B
AVANOS MEDICAL, INC (AVNS)	$1.1B